Finished
CyberKnife for Prostate Cancer Patients Aged 70 y or More
NCT03235557 · Centre Francois Baclesse, Luxembourg · Updated 22 June 2022
- What is being tested
- Not stated
- For
- Prostate Cancer
- Kind of study
- Watches patients without assigning a treatment. No drug phase (a device or procedure study).
- Who can join
- Ages 70 years and older. About 150 people. The full rules are on the registry page.
- Where
- Luxembourg
- When
- Starts or started Oct 2014, ends Dec 2021. Registered 1 Aug 2017.
- Results
- None posted yet.
In the researchers' words
Robotic Stereotactic Radiation treatment of prostatic adenocarcinoma of the elderly. Inclusion criteria : T1-T3b, MRI pelvic nodes negative, M0, any Gleason Score, PSA (Prostate Specific Antigen) \<30ng/ml. Dose : 36.25 Gy in 5 fractions, in 10 days, considering CAPRA Scores≤5 AND 37.5 Gy in 5 fractions, in 10 days, considering CAPRA Scores\>5. Primary objective : acute and late toxicity evaluation at 36 months. Secondary objectives : PSA and MRI response.
Sites
- Centre Francois BaclesseEsch-sur-Alzette, Luxembourg